Press Releases Vivani Medical, Inc.

Equities

VANI

US92854B1098

End-of-day quote Nasdaq Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
1.63 ^USD	-0.61%		-2.40%	+59.80%

05-13	Vivani Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-26	Vivani Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant	05-28	BU
Vivani Medical : 2024 Investor Presentation	05-13	PU
Vivani Medical: Q1 Earnings Snapshot	05-13	AQ
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results	05-13	BU
Vivani Medical to Present at TIDES Conference 2024	05-09	BU
Vivani Medical : 2024 Investor Presentation	03-26	PU
Vivani Medical: Q4 Earnings Snapshot	03-26	AQ
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	03-26	BU
Vivani Medical Appoints Daniel Bradbury to its Board of Directors	03-06	BU
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants	03-04	AQ
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants	03-01	BU
Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic, Wegovy	02-29	AQ
Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio	02-28	BU
Vivani Medical: Q3 Earnings Snapshot	11-14	AQ
Vivani Medical Provides Business Update and Reports Third Quarter Financial Results	11-14	BU
Vivani Medical to Present at BIO Investor Forum	23-10-16	BU
Vivani Medical : 2023 Investor Presentation	23-09-18	PU
Vivani Medical to Present at the Boulder Peptide Symposium	23-09-07	BU
Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10	23-09-05	BU
Vivani Medical : 2023 Investor Presentation	23-08-29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Vivani Medical, Inc.

Equities

VANI

US92854B1098

Press Releases

Filters